JP2023543351A5 - - Google Patents

Info

Publication number
JP2023543351A5
JP2023543351A5 JP2023542827A JP2023542827A JP2023543351A5 JP 2023543351 A5 JP2023543351 A5 JP 2023543351A5 JP 2023542827 A JP2023542827 A JP 2023542827A JP 2023542827 A JP2023542827 A JP 2023542827A JP 2023543351 A5 JP2023543351 A5 JP 2023543351A5
Authority
JP
Japan
Prior art keywords
composition according
sequence
sequence identity
amino acid
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023542827A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023543351A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/051142 external-priority patent/WO2022061247A2/en
Publication of JP2023543351A publication Critical patent/JP2023543351A/ja
Publication of JP2023543351A5 publication Critical patent/JP2023543351A5/ja
Pending legal-status Critical Current

Links

JP2023542827A 2020-09-18 2021-09-20 効率的かつ特異的なゲノム編集のためのコンストラクト及びその使用 Pending JP2023543351A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063080552P 2020-09-18 2020-09-18
US63/080,552 2020-09-18
US202163185315P 2021-05-06 2021-05-06
US63/185,315 2021-05-06
PCT/US2021/051142 WO2022061247A2 (en) 2020-09-18 2021-09-20 Constructs and uses thereof for efficient and specific genome editing

Publications (2)

Publication Number Publication Date
JP2023543351A JP2023543351A (ja) 2023-10-13
JP2023543351A5 true JP2023543351A5 (https=) 2024-09-17

Family

ID=80777856

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023542827A Pending JP2023543351A (ja) 2020-09-18 2021-09-20 効率的かつ特異的なゲノム編集のためのコンストラクト及びその使用

Country Status (6)

Country Link
US (2) US12571006B2 (https=)
EP (1) EP4214311A2 (https=)
JP (1) JP2023543351A (https=)
AU (1) AU2021343526A1 (https=)
CA (1) CA3193089A1 (https=)
WO (1) WO2022061247A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015330699B2 (en) 2014-10-10 2021-12-02 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
WO2022147157A1 (en) * 2020-12-31 2022-07-07 Gigamune, Inc. Novel nucleic acid-guided nucleases
AU2022227650A1 (en) * 2021-02-25 2023-10-12 Celyntra Therapeutics Sa Compositions and methods for targeting, editing, or modifying genes
WO2024042168A1 (en) * 2022-08-26 2024-02-29 UCB Biopharma SRL Novel rna-guided nucleases and nucleic acid targeting systems comprising such rna-guided nucleases
IL321270A (en) * 2022-12-13 2025-08-01 Bayer Ag Engineered RNA-type programmable endonucleases and their uses

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013266968B2 (en) 2012-05-25 2017-06-29 Emmanuelle CHARPENTIER Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
CA2969619A1 (en) 2014-12-03 2016-06-09 Agilent Technologies, Inc. Guide rna with chemical modifications
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
CN108690845B (zh) * 2017-04-10 2021-04-27 中国科学院动物研究所 基因组编辑系统和方法
US20210139889A1 (en) * 2017-06-19 2021-05-13 Yale University Compositions and Methods for Multiplexed Genome Editing and Screening
US9982279B1 (en) 2017-06-23 2018-05-29 Inscripta, Inc. Nucleic acid-guided nucleases
JP7689949B2 (ja) 2019-10-03 2025-06-09 アーティサン ディベロップメント ラブズ インコーポレイテッド 操作されたデュアルガイド核酸を有するcrisprシステム
WO2021074191A1 (en) 2019-10-14 2021-04-22 KWS SAAT SE & Co. KGaA Mad7 nuclease in plants and expanding its pam recognition capability
US11453907B2 (en) * 2020-03-23 2022-09-27 The Broad Institute, Inc. Crispr effector system based coronavirus diagnostics

Similar Documents

Publication Publication Date Title
JP2023543351A5 (https=)
US9040677B2 (en) Transcription activator-like effector assembly
JP2023517041A5 (https=)
JP2023541400A5 (https=)
JP2023540797A5 (https=)
FI4118198T3 (fi) Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja käyttömenetelmiä
ES2589784T3 (es) Polipéptido
PH12020551957A1 (en) Codon-optimized acid alpha-glucosidase expression cassettes and methods of using same
FI3765615T3 (fi) Uusia DNA:han kohdentuvia CRISPR-entsyymejä ja järjestelmiä
MX2019015502A (es) L-asparaginasa modificada.
JP2024535672A5 (https=)
RU2020102451A (ru) Направляемые нуклеиновыми кислотами нуклеазы
MY160897A (en) Polypeptide having or assisting in carbohydrate material degrading activity and uses thereof
MX2011011215A (es) Polipeptido que degrada carbohidratos y usos del mismo.
EP3341477A1 (en) Engineered crispr-cas9 nucleases
KR870002257A (ko) 히루딘을 유전공학적으로 제조하는 방법
MX2020005324A (es) Microorganismo modificado geneticamente para producir acido 3-hidroxidadipico, acido alfa-hidromuconico y/o acido adipico, y metodo de produccion para tales productos quimicos.
MX353906B (es) Metodo para la produccion de acidos grasos poli-insaturados en organismos transgenicos.
JP2010501167A5 (https=)
AR083848A1 (es) Polipeptidos con actividad de fosfolipasa c y polinucleotidos que los codifican
CN102787125A (zh) 一种构建tale重复序列的方法
CN111394337A (zh) II类V型CRISPR蛋白Lb2Cas12a及其在基因编辑的应用
Creti et al. Complete nucleotide sequence of an archaeal (Pyrococcus woesei) gene encoding a homolog of eukaryotic transcription factor IIB (TFIIB)
MX2010000236A (es) Variantes de empalme cd44 en enfermedades neurodegenerativas.
JP2013526840A5 (https=)